Literature DB >> 30056012

Potentially Inappropriate Prescribing in Belgian Nursing Homes: Prevalence and Associated Factors.

Pauline M S Anrys1, Goedele C Strauven2, Veerle Foulon2, Jean-Marie Degryse3, Séverine Henrard4, Anne Spinewine5.   

Abstract

BACKGROUND/
OBJECTIVES: Our aim was to describe the prevalence of potentially inappropriate medications (PIMs) and potential prescribing omissions (PPOs) in Belgian nursing homes and to identify characteristics of residents, general practitioners (GPs), and nursing homes (NHs) that are associated with the number of PIMs and PPOs.
DESIGN: A cross-sectional study.
SETTING: and Participants: Nursing home residents (NHRs), aged ≥65 years, not in palliative care were included in 54 Belgian NHs participating in the COME-ON study. MEASURES: Instances of PIMs were detected using a combination of the STOPP v2 and AGS 2015 Beers criteria. Instances of PPOs were detected using START v2. To assess factors associated with the number of PIMs and PPOs, a multivariate binomial negative regression analysis was performed.
RESULTS: A total of 1410 residents, with a median age of 87 years, was included. The median number of medications taken was 9. PIMs were detected in 88.3% of NHRs and PPOs in 85.0%. Use of benzodiazepines (46.7%) and omission of vitamin D (51.5%) were the most common PIM and PPO, respectively. The factor most strongly associated with increased PIMs was the use of 5 to 9 drugs or ≥10 drugs [relative risk (RR) (95% confidence interval [CI]: 2.27 (1.89, 2.76) and 4.04 (3.37, 4.89), respectively]. The resident's age was associated with both decreased PIMs and increased PPOs. PIMs and PPOs were also associated with some NH characteristics, but not with GP characteristics.
CONCLUSION: Implications: The high prevalence of PIMs and PPOs remains a major challenge for the NH setting. Future interventions should target in priority residents taking at least 10 medications and/or those taking psychotropic drugs. Future studies should explore factors related to organizational and prescribing culture. Moreover, special attention must be paid to the criteria used to measure inappropriate prescribing, including criteria relative to underuse.
Copyright © 2018 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Beers criteria; Inappropriate prescribing; STOPP/START; nursing homes

Mesh:

Year:  2018        PMID: 30056012     DOI: 10.1016/j.jamda.2018.06.010

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  7 in total

1.  Reducing Psychotropic Drug Use in Nursing Homes in Belgium: An Implementation Study for the Roll-Out of a Practice Improvement Initiative.

Authors:  Maarten Wauters; Monique Elseviers; Laurine Peeters; Dirk De Meester; Thierry Christiaens; Mirko Petrovic
Journal:  Drugs Aging       Date:  2019-08       Impact factor: 3.923

2.  Healthcare Costs Associated with Potentially Inappropriate Medication Prescribing Detected by Computer Algorithm Among Older Patients.

Authors:  Arnaud Pagès; Nadège Costa; Michaël Mounié; Philippe Cestac; Philipe De Souto Barreto; Yves Rolland; Bruno Vellas; Laurent Molinier; Blandine Juillard-Condat
Journal:  Drugs Aging       Date:  2022-05-24       Impact factor: 3.923

3.  Attitudes and beliefs of older adults and caregivers towards deprescribing in French-speaking countries: a multicenter cross-sectional study.

Authors:  Barbara Roux; Bianca Rakheja; Caroline Sirois; Anne Niquille; Catherine Pétein; Nicole Ouellet; Anne Spinewine; François-Xavier Sibille; Marie-Laure Laroche
Journal:  Eur J Clin Pharmacol       Date:  2022-07-27       Impact factor: 3.064

4.  Frailty and Drug Safety at Older Ages.

Authors:  Martin Gulliford
Journal:  Drug Saf       Date:  2019-06       Impact factor: 5.606

Review 5.  Interventions to optimize medication use in nursing homes: a narrative review.

Authors:  Anne Spinewine; Perrine Evrard; Carmel Hughes
Journal:  Eur Geriatr Med       Date:  2021-03-09       Impact factor: 1.710

6.  The impact of medication review with version 2 STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria in a French nursing home: a 3-month follow-up study.

Authors:  Marie-Line Gaubert-Dahan; Abdellatif Sebouai; Wafaa Tourid; Francis Fauvelle; Raoul Aikpa; Dominique Bonnet-Zamponi
Journal:  Ther Adv Drug Saf       Date:  2019-06-09

7.  Longitudinal data of multimorbidity and polypharmacy in older adults in Taiwan from 2000 to 2013.

Authors:  Shih-Wei Lai; Kuan-Fu Liao; Cheng-Li Lin; Cheng-Chieh Lin; Chih-Hsueh Lin
Journal:  Biomedicine (Taipei)       Date:  2020-06-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.